{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:11:24Z","timestamp":1759191084606,"version":"3.44.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82174158"],"award-info":[{"award-number":["82174158"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019978","name":"Shanghai Pudong New Area Health Commission","doi-asserted-by":"publisher","award":["PWR12023-06"],"award-info":[{"award-number":["PWR12023-06"]}],"id":[{"id":"10.13039\/501100019978","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shanghai Hongkou District Health Commission","award":["2202-37"],"award-info":[{"award-number":["2202-37"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Behav Brain Funct"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Pleckstrin homology (PH) domain leucine-rich repeat protein phosphatases (PHLPP) has been associated with several neurodegenerative diseases, however, few studies have investigated the role of PHLPP in Parkinson\u2019s disease (PD). The present study aimed to answer this question through establishing a Parkinson\u2019s disease (PD) model using the Phlpp1-\/- and wild-type (WT) mice and testing their behavioral as well as molecular changes. Methods: MPTP was intraperitoneal injected into mice to generate a PD model. Neurobehavioral parameters, protein expression and inflammatory cytokines release were measured by the open filed test, the pole test, immunohistochemistry, immunoblotting, immunoprecipitation, and quantitative reverse transcription PCR.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>MPTP-induced neurobehavioral deficits were more significantly ameliorated in PHLPP-KO-MPTP mice compared to WT-MPTP mice. The survival rate of TH<jats:sup>+<\/jats:sup> neurons in the PHLPP-KO-MPTP group was higher than that in the WT-MPTP group (66% vs. 38%). Additionally, PHLPP1 knockout in KO-MPTP mice markedly reduced levels of IL-1\u03b2, IL-6, TNF-\u03b1, and iNOS, and increased levels of TGF-\u03b2 compared to those of WT-MPTP mice. Furthermore, PHLPP1 was found to bind to NLRP3 and that PHLPP1 knockout inhibited MPTP-induced expression of IL-1\u03b2 and caspase-1 in substantia nigra of PD model mice.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Our results demonstrates that PHLPP1 knockout in PD model is positively associated with the survival of TH\u2009+\u2009neurons by suppressing inflammatory response in substantia nigra, suggesting that PHLPP1 plays a critical role in the development of PD.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12993-025-00293-y","type":"journal-article","created":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T13:20:10Z","timestamp":1759152010000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["PHLPP1 deficiency alleviates dopaminergic neurodegeneration and represses neuroinflammation in Parkinson\u2019s disease"],"prefix":"10.1186","volume":"21","author":[{"given":"Zhilin","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinyue","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yudi","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zikai","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huazheng","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Bi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,29]]},"reference":[{"key":"293_CR1","first-page":"896","volume":"386","author":"LV Kalia","year":"2015","unstructured":"Kalia LV, Lang AE. Parkinson\u2019s Disease Lancet. 2015;386:896\u2013912.","journal-title":"Parkinson\u2019s Disease Lancet"},{"key":"293_CR2","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.neuroscience.2014.12.052","volume":"292","author":"S Mitra","year":"2015","unstructured":"Mitra S, Chakrabarti N, Dutta SS, Ray S, Bhattacharya P, Sinha P, Bhattacharyya A. Gender-specific brain regional variation of neurons, endogenous estrogen, neuroinflammation and glial cells during rotenone-induced mouse model of parkinson\u2019s disease. Neuroscience. 2015;292:46\u201370.","journal-title":"Neuroscience"},{"key":"293_CR3","doi-asserted-by":"publisher","first-page":"13949","DOI":"10.1038\/srep13949","volume":"5","author":"S Mitra","year":"2015","unstructured":"Mitra S, Ghosh N, Sinha P, Chakrabarti N, Bhattacharyya A. Alteration in nuclear Factor-KappaB pathway and functionality of Estrogen via receptors promote neuroinflammation in frontal cortex after 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine treatment. Sci Rep. 2015;5:13949.","journal-title":"Sci Rep"},{"key":"293_CR4","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.neuint.2018.01.006","volume":"114","author":"W Wang","year":"2018","unstructured":"Wang W, Song N, Jia F, Tang T, Bao W, Zuo C, Xie J, Jiang H. Genomic DNA levels of mutant Alpha-synuclein correlate with Non-Motor symptoms in an A53T parkinson\u2019s disease mouse model. Neurochem Int. 2018;114:71\u20139.","journal-title":"Neurochem Int"},{"key":"293_CR5","doi-asserted-by":"publisher","first-page":"369","DOI":"10.3389\/fnins.2019.00369","volume":"13","author":"E Fitzgerald","year":"2019","unstructured":"Fitzgerald E, Murphy S, Martinson HA. Alpha-synuclein pathology and the role of the microbiota in parkinson\u2019s disease. Front Neurosci. 2019;13:369.","journal-title":"Front Neurosci"},{"key":"293_CR6","doi-asserted-by":"crossref","unstructured":"Xu L, Pu J. Alpha-Synuclein in Parkinson\u2019s Disease: From Pathogenetic Dysfunction to Potential Clinical Application. Park. Dis. 2016;2016:1720621.","DOI":"10.1155\/2016\/1720621"},{"key":"293_CR7","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/nature11748","volume":"494","author":"W Shao","year":"2013","unstructured":"Shao W, et al. Suppression of neuroinflammation by astrocytic dopamine D2 receptors via alphaB-crystallin. Nature. 2013;494:90\u20134.","journal-title":"Nature"},{"key":"293_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jchemneu.2016.11.009","volume":"80","author":"SK Yadav","year":"2017","unstructured":"Yadav SK, Rai SN, Singh SP. Mucuna pruriens reduces inducible nitric oxide synthase expression in parkinsonian mice model. J Chem Neuroanat. 2017;80:1\u201310.","journal-title":"J Chem Neuroanat"},{"key":"293_CR9","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jchemneu.2015.12.002","volume":"71","author":"SN Rai","year":"2016","unstructured":"Rai SN, Yadav SK, Singh D, Singh SP. Ursolic acid attenuates oxidative stress in nigrostriatal tissue and improves neurobehavioral activity in MPTP-induced parkinsonian mouse model. J Chem Neuroanat. 2016;71:41\u20139.","journal-title":"J Chem Neuroanat"},{"issue":"12","key":"293_CR10","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1007\/s11064-014-1443-7","volume":"39","author":"J Prakash","year":"2014","unstructured":"Prakash J, Chouhan S, Yadav SK, Westfall S, Rai SN, Singh SP. Withania somnifera alleviates parkinsonian phenotypes by inhibiting apoptotic pathways in dopaminergic neurons. Neurochem Res. 2014;39(12):2527\u201336.","journal-title":"Neurochem Res"},{"issue":"3","key":"293_CR11","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3390\/diseases11030089","volume":"11","author":"K Ramakrishna","year":"2023","unstructured":"Ramakrishna K, Nalla LV, Naresh D, Venkateswarlu K, Viswanadh MK, Nalluri BN, Chakravarthy G, Duguluri S, Singh P, Rai SN, Kumar A, Singh V, Singh SK. WNT-\u03b2 Catenin signaling as a potential therapeutic target for neurodegenerative diseases: current status and future perspective. Diseases. 2023;11(3):89.","journal-title":"Diseases"},{"issue":"4","key":"293_CR12","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1161\/CIRCRESAHA.109.215020","volume":"107","author":"S Miyamoto","year":"2010","unstructured":"Miyamoto S, Purcell NH, Smith JM, Gao T, Whittaker R, Huang K, Castillo R, Glembotski CC, Sussman MA, Newton AC, Heller Brown J. PHLPP-1 negatively regulates Akt activity and survival in the heart. Circ Res. 2010;107(4):476\u201384.","journal-title":"Circ Res"},{"issue":"22","key":"293_CR13","doi-asserted-by":"publisher","first-page":"19777","DOI":"10.1074\/jbc.M111.237081","volume":"286","author":"NA Warfel","year":"2011","unstructured":"Warfel NA, Niederst M, Stevens MW, Brennan PM, Frame MC, Newton AC. Mislocalization of the E3 ligase, \u03b2-transducin repeat-containing protein 1 (\u03b2-TrCP1), in glioblastoma uncouples negative feedback between the pleckstrin homology domain leucine-rich repeat protein phosphatase 1 (PHLPP1) and Akt. J Biol Chem. 2011;286(22):19777\u201388.","journal-title":"J Biol Chem"},{"issue":"2","key":"293_CR14","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1038\/jcbfm.2012.150","volume":"33","author":"B Chen","year":"2013","unstructured":"Chen B, van Winkle JA, Lyden PD, Brown JH, Purcell NH. PHLPP1 gene deletion protects the brain from ischemic injury. J Cereb Blood Flow Metab. 2013;33(2):196\u2013204.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"2","key":"293_CR15","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1124\/jpet.113.206888","volume":"347","author":"TC Jackson","year":"2013","unstructured":"Jackson TC, Verrier JD, Drabek T, Janesko-Feldman K, Gillespie DG, Uray T, Dezfulian C, Clark RS, Bayir H, Jackson EK, Kochanek PM. Pharmacological Inhibition of pleckstrin homology domain leucine-rich repeat protein phosphatase is neuroprotective: differential effects on astrocytes s. J Pharmacol Exp Ther. 2013;347(2):516\u201328.","journal-title":"J Pharmacol Exp Ther"},{"issue":"6","key":"293_CR16","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1016\/j.cell.2006.12.047","volume":"128","author":"K Shimizu","year":"2007","unstructured":"Shimizu K, Phan T, Mansuy IM, Storm DR. Proteolytic degradation of SCOP in the hippocampus contributes to activation of MAP kinase and memory. Cell. 2007;128(6):1219\u201329.","journal-title":"Cell"},{"issue":"7","key":"293_CR17","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.1073\/pnas.90.7.2628","volume":"90","author":"K-I Saito","year":"1993","unstructured":"Saito K-I, Elcet JS, Hamos JE, Nixon RA. Widespread activation of calciumactivated neutral proteinase (calpain) in the brain in alzheimer disease: a potential molecular basis for neuronal degeneration. Proc Natl Acad Sci U S A. 1993;90(7):2628\u201332.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"293_CR18","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1038\/cdd.2009.127","volume":"17","author":"A Saavedra","year":"2010","unstructured":"Saavedra A, Garc\u00eda-Mart\u00ednez JM, Xifro X, Giralt A, Torres-Peraza JF, Canals JM, D\u00edaz-Hernandez M, Lucas JJ, Alberch J, P\u00b4erez-Navarro E. PH domain leucine-rich repeat protein phosphatase 1 contributes to maintain the activation of the PI3K\/Akt pro-survival pathway in huntington\u2019s disease striatum. Cell Death Differ. 2010;17(2):324\u201335.","journal-title":"Cell Death Differ"},{"issue":"1","key":"293_CR19","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/nprot.2006.342","volume":"2","author":"V Jackson-Lewis","year":"2007","unstructured":"Jackson-Lewis V, Przedborski S. Protocol for the MPTP mouse model of parkinson\u2019s disease. Nat Protoc. 2007;2(1):141\u201351.","journal-title":"Nat Protoc"},{"key":"293_CR20","doi-asserted-by":"publisher","first-page":"101752","DOI":"10.1016\/j.jchemneu.2020.101752","volume":"104","author":"SN Rai","year":"2020","unstructured":"Rai SN, Singh P. Advancement in the modelling and therapeutics of parkinson\u2019s disease. J Chem Neuroanat. 2020;104:101752.","journal-title":"J Chem Neuroanat"},{"key":"293_CR21","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.brainresbull.2019.12.013","volume":"156","author":"P Sinha","year":"2020","unstructured":"Sinha P, Chakrabarti N, Ghosh N, Mitra S, Dalui S, Bhattacharyya A. Alterations of thyroidal status in brain regions and hypothalamo-pituitary-blood-thyroid-axis associated with dopaminergic depletion in substantia Nigra and ROS formation in different brain regions after MPTP treatment in adult male mice. Brain Res Bull. 2020;156:131\u201340.","journal-title":"Brain Res Bull"},{"issue":"6","key":"293_CR22","first-page":"567","volume":"30","author":"Y Huang","year":"2014","unstructured":"Huang Y, Liu Z, Wang XQ, Qiu YH, Peng YP. A dysfunction of CD4\u2009+\u2009T lymphocytes in peripheral immune system of parkinson\u2019s disease model mice. Zhongguo Ying Yong Sheng Li Xue Za Zhi. 2014;30(6):567\u201376.","journal-title":"Zhongguo Ying Yong Sheng Li Xue Za Zhi"},{"issue":"9","key":"293_CR23","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1038\/aps.2012.88","volume":"33","author":"DD Wu","year":"2012","unstructured":"Wu DD, Huang L, Zhang L, Wu LY, Li YC, Feng L. LLDT-67 attenuates MPTP-induced neurotoxicity in mice by up-regulating NGF expression. Acta Pharmacol Sin. 2012;33(9):1187\u201394.","journal-title":"Acta Pharmacol Sin"},{"issue":"12","key":"293_CR24","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1038\/ni1275","volume":"6","author":"AD Luster","year":"2005","unstructured":"Luster AD, Alon R, von Andrian UH. Immune cell migration in inflammation: present and future therapeutic targets. Nat Immunol. 2005;6(12):1182\u201390.","journal-title":"Nat Immunol"},{"issue":"2","key":"293_CR25","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1073\/pnas.0307453101","volume":"101","author":"S Hunot","year":"2004","unstructured":"Hunot S, Vila M, Teismann P, Davis RJ, Hirsch EC, Przedborski S, Rakic P, Flavell RA. JNK-mediated induction of cyclooxygenase 2 is required for neurodegeneration in a mouse model of parkinson\u2019s disease. Proc Natl Acad Sci U S A. 2004;101(2):665\u201370.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"293_CR26","doi-asserted-by":"crossref","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (San Diego, Calif.), 2001;25(4):402\u2013408.","DOI":"10.1006\/meth.2001.1262"},{"issue":"3","key":"293_CR27","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1111\/jnc.14683","volume":"150","author":"W Boonying","year":"2019","unstructured":"Boonying W, Joselin A, Huang E, Qu D, Safarpour F, Iyirhiaro GO, Gonzalez YR, Callaghan SM, Slack RS, Figeys D, Chung YH, Park DS. Pink1 regulates FKBP5 interaction with AKT\/PHLPP and protects neurons from neurotoxin stress induced by MPP+. J Neurochem. 2019;150(3):312\u201329.","journal-title":"J Neurochem"},{"issue":"4","key":"293_CR28","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1111\/j.1471-4159.2010.06984.x","volume":"115","author":"TC Jackson","year":"2010","unstructured":"Jackson TC, Verrier JD, Semple-Rowland S, Kumar A, Foster TC. PHLPP1 splice variants differentially regulate AKT and PKC\u03b1 signaling in hippocampal neurons: characterization of PHLPP proteins in the adult hippocampus. J Neurochem. 2010;115(4):941\u201355.","journal-title":"J Neurochem"},{"issue":"6","key":"293_CR29","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1002\/ddr.22077","volume":"84","author":"AMA El-Latif","year":"2023","unstructured":"El-Latif AMA, Rabie MA, Sayed RH, Fattah MAAE, Kenawy SA. Inosine attenuates rotenone-induced parkinson\u2019s disease in rats by alleviating the imbalance between autophagy and apoptosis. Drug Dev Res. 2023;84(6):1159\u201374.","journal-title":"Drug Dev Res"},{"key":"293_CR30","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1212\/WNL.38.8.1285","volume":"38","author":"PL McGeer","year":"1988","unstructured":"McGeer PL, Itagaki S, Boyes BE, McGeer EG. Reactive microglia are positive for HLA-DR in the substantia Nigra of parkinson\u2019s and alzheimer\u2019s disease brains. Neurology. 1988;38:1285\u201391.","journal-title":"Neurology"},{"key":"293_CR31","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S0074-7742(07)82012-5","volume":"82","author":"J Rogers","year":"2007","unstructured":"Rogers J, Mastroeni D, Leonard B, Joyce J, Grover A. Neuroinflammation in alzheimer\u2019s disease and parkinson\u2019s disease: are microglia pathogenic in either disorder? Int Rev Neurobiol. 2007;82:235\u201346.","journal-title":"Int Rev Neurobiol"},{"key":"293_CR32","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.neuroscience.2017.11.041","volume":"369","author":"D Huang","year":"2018","unstructured":"Huang D, Wang Z, Tong J, Wang M, Wang J, Xu J, Bai X, Li H, Huang Y, Wu Y, Ma Y, Yu M, Huang F. Long-term changes in the nigrostriatal pathway in the MPTP mouse model of parkinson\u2019s disease. Neuroscience. 2018;369:303\u201313.","journal-title":"Neuroscience"},{"key":"293_CR33","doi-asserted-by":"crossref","unstructured":"Liddelow, S. A., Guttenplan, K. A., Clarke, L. E., Bennett, F. C., Bohlen, C. J.,Schirmer, L., Bennett, M. L., M\u00fcnch, A. E., Chung, W. S., Peterson, T. C., Wilton,D. K., Frouin, A., Napier, B. A., Panicker, N., Kumar, M., Buckwalter, M. S., Rowitch,D. H., Dawson, V. L., Dawson, T. M., Stevens, B., \u2026 Barres, B. A. Neurotoxic reactive astrocytes are induced by activated microglia. Nature, 2017;541(7638):481\u2013487.","DOI":"10.1038\/nature21029"},{"key":"293_CR34","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/1742-2094-8-163","volume":"8","author":"S Mitra","year":"2011","unstructured":"Mitra S, Chakrabarti N, Bhattacharyya A. Differential regional expression patterns of \u03b1-synuclein, TNF-\u03b1, and IL-1\u03b2; and variable status of dopaminergic neurotoxicity in mouse brain after Paraquat treatment. J Neuroinflamm. 2011;8:163.","journal-title":"J Neuroinflamm"},{"key":"293_CR35","doi-asserted-by":"publisher","first-page":"1396345","DOI":"10.3389\/fnins.2024.1396345","volume":"18","author":"X Qin","year":"2024","unstructured":"Qin X, Wang S, Huang J, Hu B, Yang X, Liang L, Zhou R, Huang W. Rhein alleviates MPTP-induced parkinson\u2019s disease by suppressing neuroinflammation via MAPK\/I\u03baB pathway. Front NeuroSci. 2024;18:1396345.","journal-title":"Front NeuroSci"},{"key":"293_CR36","doi-asserted-by":"publisher","first-page":"e55375","DOI":"10.1371\/journal.pone.0055375","volume":"8","author":"G Codolo","year":"2013","unstructured":"Codolo G, Plotegher N, Pozzobon T, et al. Triggering of inflammasome by aggregated alpha- synuclein, an inflammatory response in synucleinopathies. PLoS ONE. 2013;8:e55375.","journal-title":"PLoS ONE"},{"issue":"2","key":"293_CR37","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.jmb.2017.11.013","volume":"430","author":"MM Gaidt","year":"2018","unstructured":"Gaidt MM, Hornung V. The NLRP3 inflammasome renders cell death Pro-inflammatory. J Mol Biol. 2018;430(2):133\u201341.","journal-title":"J Mol Biol"},{"issue":"6","key":"293_CR38","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.cell.2010.01.040","volume":"140","author":"K Schroder","year":"2010","unstructured":"Schroder K, Tschopp J. The inflammasomes. Cell. 2010;140(6):821\u201332.","journal-title":"Cell"},{"issue":"8","key":"293_CR39","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","volume":"19","author":"KV Swanson","year":"2019","unstructured":"Swanson KV, Deng M, Ting JP. The NLRP3 inflammasome: molecular activation and regulation to therapeutics. Nat Rev Immunol. 2019;19(8):477\u201389.","journal-title":"Nat Rev Immunol"},{"key":"293_CR40","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.cytogfr.2020.08.003","volume":"55","author":"A Gritsenko","year":"2020","unstructured":"Gritsenko A, Green JP, Brough D, Lopez-Castejon G. Mechanisms of NLRP3 priming in inflammaging and age related diseases. Cytokine Growth Factor Rev. 2020;55:15\u201325.","journal-title":"Cytokine Growth Factor Rev"},{"key":"293_CR41","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/nrneurol.2014.226","volume":"11","author":"D Athauda","year":"2015","unstructured":"Athauda D, Foltynie T. The ongoing pursuit of neuroprotective therapies in Parkinson disease. Nat Rev Neurol. 2015;11:25\u201340.","journal-title":"Nat Rev Neurol"},{"key":"293_CR42","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/nrn.2017.75","volume":"18","author":"JB Koprich","year":"2017","unstructured":"Koprich JB, Kalia LV, Brotchie JM. Animal models of sncaopathy for Parkinson disease drug development. Nat Rev Neurosci. 2017;18:515\u201329.","journal-title":"Nat Rev Neurosci"},{"issue":"1","key":"293_CR43","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1186\/s12974-020-01981-4","volume":"17","author":"B Ding","year":"2020","unstructured":"Ding B, Lin C, Liu Q, He Y, Ruganzu JB, Jin H, Peng X, Ji S, Ma Y, Yang W. Tanshinone IIA attenuates neuroinflammation via inhibiting RAGE\/NF-\u03baB signaling pathway in vivo and in vitro. J Neuroinflamm. 2020;17(1):302.","journal-title":"J Neuroinflamm"},{"issue":"1\u20132","key":"293_CR44","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.cell.2014.11.047","volume":"160","author":"Y An","year":"2015","unstructured":"An Y, Jiang W, Liu L, Wang X, Ding C, Tian Z, Zhou R. Dopamine controls systemic inflammation through Inhibition of NLRP3 inflammasome. Cell. 2015;160(1\u20132):62\u201373.","journal-title":"Cell"},{"issue":"6","key":"293_CR45","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1002\/glia.23970","volume":"69","author":"AF Pike","year":"2021","unstructured":"Pike AF, Varanita T, Herrebout MAC, Plug BC, Kole J, Musters RJP, Teunissen CE, Hoozemans JJM, Bubacco L, Veerhuis R. \u03b1-Synuclein evokes NLRP3 inflammasome-mediated IL-1\u03b2 secretion from primary human microglia. Glia. 2021;69(6):1413\u201328.","journal-title":"Glia"}],"container-title":["Behavioral and Brain Functions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12993-025-00293-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12993-025-00293-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12993-025-00293-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T14:03:45Z","timestamp":1759154625000},"score":1,"resource":{"primary":{"URL":"https:\/\/behavioralandbrainfunctions.biomedcentral.com\/articles\/10.1186\/s12993-025-00293-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,29]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["293"],"URL":"https:\/\/doi.org\/10.1186\/s12993-025-00293-y","relation":{},"ISSN":["1744-9081"],"issn-type":[{"value":"1744-9081","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,29]]},"assertion":[{"value":"30 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Animal ethics approval was granted by the Animal Care and Ethics Committee of Tongji University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"29"}}